Innovative fluidics, designed for skin, high-fidelity human equivalent skin-responses in vitro, eliminates skin testing errors for clear transition to clinic
Keratify dramatically improves skin health by transforming human skin testing with breakthrough biotechnology. We eliminate the current limitations of skin testing causing compound failure rates of up to 59% resulting in 50x greater phase 1 costs, poor bench to clinic translation and loss of innovation. With over 50% of the global population suffering from skin disease, we ensure that compounds are tested effectively and eventually reach those that need it. Ros is a multi-award winning entrepreneur and researcher with a PhD in dermatoendocrinology and over 15yrs dermatology research experience. The talented Keratify team has extensive experience in a broad range of testing needs from skin computational modelling, formulation, sun care, inflammatory and endocrine responses, healthy, ageing and skin disease models. We strive to provide the best skin testing solutions that can only be addressed by our unique technology.